Dietary Histone Deacetylase Inhibitors (HDAC)
Condition(s):Histone Deacetylase (HDAC) ActivityLast Updated:April 30, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Histone Deacetylase (HDAC) ActivityLast Updated:April 30, 2019Terminated
Condition(s):Solid TumorLast Updated:November 28, 2011Completed
Condition(s):Heart Failure With Normal Ejection Fraction; Left Ventricular Hypertrophy; Aortic Valve Stenosis; DiabetesLast Updated:March 17, 2022Unknown status
Condition(s):Hodgkin’s LymphomaLast Updated:May 11, 2021Completed
Condition(s):Metastatic Gastric CancerLast Updated:May 1, 2013Terminated
Condition(s):Cervical Cancer; Cervix Cancer; Cervix NeoplasmLast Updated:December 7, 2020Unknown status
Condition(s):MelanomaLast Updated:December 14, 2015Completed
Condition(s):Advanced Hematologic MalignanciesLast Updated:April 1, 2015Completed
Condition(s):Leiomyosarcoma; Endometrial Stromal Tumors; Carcinosarcomas UterineLast Updated:August 4, 2020Terminated
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:November 3, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.